The association between HMGA1 rs146052672 variant and type 2 diabetes: A transethnic meta-analysis

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Bianco, Aida ^a   Chiefari, Eusebio ^a   Nobile, Carmelo G A ^a   Foti, Daniela ^a   Pavia, Maria ^a   Brunetti, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A1B PROTEIN; HIGH MOBILITY GROUP A1A PROTEIN;

AFRICAN; ARTICLE; CAUCASIAN; DISEASE PREDISPOSITION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; PUBLISHING; BIOLOGICAL MODEL; ETHNOLOGY; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; ODDS RATIO; PATHOLOGY; RISK;

DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HMGA1A PROTEIN; HUMANS; INSULIN RESISTANCE; MODELS, GENETIC; ODDS RATIO; RISK;

EID: 84943170617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136077     Document Type: Article

References (60)

1. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: pathogenesis and treatment. Lancet. 2008; 371: 2153-2156. doi: 10.1016/S0140-6736(08)60932-0 PMID: 18586159
2. Unger RH. Reinventing type 2 diabetes: pathogenesis, treatment, and prevention. JAMA. 2008; 299: 1185-1187. doi: 10.1001/jama.299.10.1185 PMID: 18334695
3. Wild S, Roglic G, Green A, Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27:1047-1053. PMID: 15111519
4. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962; 14: 353-362. PMID: 13937884
5. Brunetti A, Chiefari E, Foti D. Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes. 2014; 5:128-140. doi: 10.4239/wjd.v5.i2.128 PMID: 24748926
6. Doria A, Patti ME, Kahn CR. The emerging genetic architecture of type 2 diabetes. Cell Metab. 2008; 8: 186-200. doi: 10.1016/j.cmet.2008.08.006 PMID: 18762020
7. McCarthy MI, Zeggini E. Genome-wide association studies in type 2 diabetes. Curr Diab Rep. 2009; 9: 164-171. PMID: 19323962
8. Maher B. Personal genomes: The case of the missing heritability. Nature. 2008; 456:18-21. doi: 10.1038/456018a PMID: 18987709
9. Chiefari E, Tanyolaç S, Paonessa F, Pullinger CR, Capula C, Iiritano S, et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA. 2011; 305: 903-912. doi: 10.1001/jama.2011.207 PMID: 21364139
10. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene. 2001; 277: 63-81. PMID: 11602345
11. Thanos D, Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell. 1995; 83:1091-1100. PMID: 8548797
12. Brunetti A, Manfioletti G, Chiefari E., Goldfine ID, Foti D. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J. 2001; 15:492-500. PMID: 11156965
13. Foti D, Iuliano R, Chiefari E., Brunetti A. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol. 2003; 23: 2720-2732. PMID: 12665574
14. Melillo RM, Pierantoni GM, Scala S, Battista B, Fedele M, Stella A, et al. Critical role of the HMGI(Y) proteins inadipocyticcell growth and differentiation. Mol Cell Biol. 2001; 21: 2485-2495. PMID: 11259597
15. Chiefari E, Paonessa F, Iiritano S., Le Pera I, Palmieri D, Brunetti G., et al. The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biology. 2009; 7: 24. doi: 10.1186/1741-7007-7-24 PMID: 19460132
16. Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E., Nocera A, Iiritano S, et al. HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci Rep. 2012; 2: 251. doi: 10.1038/srep00251 PMID: 22355763
17. Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, et al. The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake. Mol Endocrinol. 2012; 26:1578-1589. doi: 10.1210/me.2011-1379 PMID: 22745191
18. Arcidiacono B, Iiritano S, Chiefari E., Brunetti FS, Gu G, Foti DP, et al Cooperation between HMGA1, PDX-1 and MafA is essential for glucose-induced insulin transcription in pancreatic beta cells. Front Endocrinol. 2015; 5: 237.
19. Foti D, Chiefari E, Fedele M., Iuliano R, Brunetti L, Paonessa F., et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med. 2005; 11: 765-773. PMID: 15924147
20. Chiefari E, Iiritano S, Paonessa F., Le Pera I, Arcidiacono B, Filocamo M., et al. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat Commun. 2010; 1: 40. doi: 10.1038/ncomms1040 PMID: 20975707
21. Semple RK. From bending DNA to diabetes: the curious case of HMGA1. J Biol. 2009; 8: 64. doi: 10.1186/jbiol164 PMID: 19664187
22. Marquez M, Huyvaert M, Perry JR, Pearson RD, Falchi M, Morris AP, et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes. 2012; 61: 524-530. doi: 10.2337/db11-0728 PMID: 22210315
23. Liu L, Ding H, Wang H.R., Xu YJ, Cui GL, Wang PH, et al Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals. Diabetologia. 2012; 55:1685-1688. doi: 10.1007/s00125-012-2518-0 PMID: 22411136
24. Karnes JH, Langaee TY, McDonough CW, Chang SW, Ramos M, Catlin JR Jr, et al. Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort. J Transl Med. 2013; 11:12. doi: 10.1186/1479-5876-11-12 PMID: 23302499
25. Pullinger CR, Goldfine ID, Tanyolaç S, Movsesyan I, Faynboym M, Durlach V, et al. Evidence that an HMGA1 Gene Variant Associates with Type 2 Diabetes, Body Mass Index, and High-Density Lipoprotein Cholesterol in a Hispanic-American Population. Metab Syndr Relat Disord. 2014; 12: 25-30. doi: 10.1089/met.2013.0086 PMID: 24148075
26. Chiefari E, Tanyolaç S, Iiritano S, Sciacqua A, Capula C, Arcidiacono B, et al. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep. 2013; 3:1491. doi: 10.1038/srep01491 PMID: 23512162
27. Nakaoka H, Inoue I. Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse. J Hum Genet. 2009; 54: 615-623. doi: 10.1038/jhg.2009.95 PMID: 19851339
28. Stroup DF, Berlin JA, Morton S.C., Olkin I., Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012. PMID: 10789670
29. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535.
30. Wells GA, Shea B, O'Connell D, Peterson J, Welch V., Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. Available: http://www.ohri.ca/programs/clinicalepidemiology/oxford.asp.
31. Chuan DW, Hong YZ, Wei W. Meta-analysis of the association of the Rs2234693 and Rs9340799 polymorphisms of estrogen receptor alpha gene with coronary heart disease risk in Chinese Han population. Int J Med Sci. 2013; 10: 457-466. doi: 10.7150/ijms.5234 PMID: 23471591
32. Chen T, Song DL, Shan GL. The association between diabetes mellitus and non arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. PLoS One. 2013; 8: e76653. doi: 10. 1371/journal.pone.0076653 PMID: 24098798
33. Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014; 32: 3623-3629. doi: 10.1016/j. vaccine.2014.04.085 PMID: 24814559
34. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005; 24:1291-1306. PMID: 15568190
35. Wu W, Tong Y, Wei X., Zhao Q, Pan X, Yu G., et al. Association between Int7G24A rs334354 polymorphism and cancer risk: a meta-analysis of case-control studies. Sci Rep. 2015; 5:11350. doi: 10.1038/srep11350 PMID: 26074400
36. Ye XH, Bu ZB, Feng J, Peng L, Liao XB, Zhu XL, et al. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep. 2014; 41: 373-385. doi: 10.1007/s11033-013-2871-1 PMID: 24271138
37. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-188. PMID: 3802833
38. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22: 719-748. PMID: 13655060
39. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21:1539-1558.
40. Higgins JP, Thompson SG, Deeks J.J., Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560. PMID: 12958120
41. Sterne JA, Egger M, Smith GD Investigating and dealing with publication bias and other biases in meta-analysis. BMJ. 2001; 323:101-105.
42. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1099. PMID: 7786990
43. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634. PMID: 9310563
44. Hanis CL, Hewett-Emmett D, Bertin TK, Schull WJ. Origins of U.S. Hispanics. Implications for diabetes. Diabetes Care. 1991; 14: 618-627. PMID: 1914811
45. Schneiderman N, Llabre M, Cowie C.C., Barnhart J., Carnethon M, Gallo LC, et al Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes Care. 2014; 37: 2233-2239. doi: 10.2337/dc13-2939 PMID: 25061138
46. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003; 26: no. suppl 1 s5-s20. PMID: 12502614
47. Wacholder S, Silverman DT, McLaughlin J.K., Mandel JS. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol. 1992; 135:1029-1041. PMID: 1595689
48. Rothman K, Greenland S, Lash T. Modern Epidemiology. 3rd ed. Philadelphia: Lipincott Williams and Wilkins; 2008.
49. Miettinen OS. The "case-control" study: valid selection of subjects. J Chronic Dis. 1985; 38: 543-548. PMID: 4008595
50. Genuth S, Alberti KG, Bennett P, Buse J., DeFronzo R, Kahn R, et al Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Followup report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26: 3160-3167.
51. Zhang X, Gregg EW, Williamson D.F., Barker LE, Thomas W, Bullard KM, et al A1Cleveland future risk of diabetes: a systematic review. Diabetes Care. 2010; 33:1665-1673. doi: 10.2337/dc09-1939 PMID: 20587727
52. American Diabetes Association. Standard of medical care in diabetes-2014. Diabetes Care. 2014; 37: Supplement 1.
53. Hunter LH, Robb WF, Brownie SM The "secret" impact of population statistics on the metrics of diabetes. J Diabetes Metab Disord Control. 2014; 1: 00024.
54. Zheng G, Tian X. The impact of diagnostic error on testing genetic association in case-control studies. Stat Med. 2005; 24: 869-882. PMID: 15568195
55. Fradin DD, Fallin MD Influence of control selection in genome-wide association studies: the example of diabetes in the Framingham Heart Study. BMC Proc. 2009; 3: Supplement 7.
56. Wray NR, Lee SH, Kendler KS Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes. Eur J Hum Genet. 2012; 20: 668-674. doi: 10.1038/ejhg.2011. 257 PMID: 22258521
57. Smith S, Hay el H, Farhat N, Rekaya R. Genome wide association studies in presence of misclassified binary responses. BMC Genet. 2013; 14:124. doi: 10.1186/1471-2156-14-124 PMID: 24369108
58. Ioannidis JP, Boffetta P, Little J., O'Brien TR, Uitterlinden AG, Vineis P, et al Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008; 371:120-132.
59. Brunetti A, Chiefari E, Pullinger CR, Tanyolac S, Foti D, Durlach V, et al. Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes. 2012; 61: 524-530. Diabetes. 2012; 61: e3.
60. Froguel P, Marquez M, Cauchi S. Response to comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes. 2012; 61: 524-530. Diabetes. 2012; 61: e15. doi: 10.2337/db11-0728 PMID: 22210315